V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017438 | 220008070 | 1.65 | 74 | Curative (C) | 2013-07-01 | 2013-07-01 | Triple Intrathecal | N | N | 220030735 | TRIPLE INTRATHECAL |
| 220017439 | 220008071 | 0 | 93 | Curative (C) | 2017-02-06 | 2017-02-07 | ATG + Busulfan + Fludarabine | N | null | 220030736 | ATG + BUSULFAN + FLUDARABINE |
| 220017440 | 220008072 | 1.25 | 69 | Disease modification (D) | 2011-04-16 | 2014-10-23 | ATG + Busulfan + Fludarabine | N | N | 220030737 | ATG + BUSULFAN + FLUDARABINE |
| 220017441 | 220008074 | 1.71 | 50.5 | Curative (C) | 2017-04-01 | 2017-04-01 | FLAG | N | N | 220030739 | FLAG |
| 220017442 | 220008077 | 1.28 | 113.8 | null | 2014-08-03 | 2014-08-03 | Methotrexate intrathecal | 02 | N | 220030743 | METHOTREXATE INTRATHECAL |
| 220017443 | 220008082 | 1.64 | 71.45 | Curative (C) | 2014-08-29 | 2014-10-21 | Triple / Double Intrathecal Therapy | N | N | 220030754 | TRIPLE INTRATHECAL |
| 220017444 | 220008087 | null | 80.8 | Palliative (P) | 2014-08-04 | 2014-08-06 | AML16 DA 3+10 | N | N | 220030766 | AML16 TRIAL |
| 220017445 | 220008089 | null | 60.9 | Curative (C) | null | 2016-10-13 | BOSUTINIB | N | N | 220030766 | BOSUTINIB |
| 220017447 | 220020925 | null | 80.3 | Palliative (P) | 2017-08-21 | 2017-08-21 | Triple Intrathecal | 02 | N | 220030783 | TRIPLE INTRATHECAL |
| 220017448 | 220008094 | 1.73 | 100.3 | Palliative (P) | 2013-12-05 | 2014-09-24 | AML Int Guide ADE 10+3+5 (1) | N | N | 220030802 | ADE |
| 220017449 | 220008094 | 1.68 | 56 | Disease modification (D) | 2015-10-01 | 2015-10-01 | Triple / Double Intrathecal Therapy | N | N | 220030802 | TRIPLE INTRATHECAL |
| 220017451 | 220008100 | 1.67 | 155 | Curative (C) | 2017-04-04 | 2017-04-04 | AML16 DA 3+10 | 02 | N | 220030811 | AML16 TRIAL |
| 220017452 | 220017872 | 0 | 43.4 | Curative (C) | 2013-08-24 | 2013-08-27 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220030823 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017453 | 220008103 | null | 56.7 | Curative (C) | 2014-05-11 | 2014-06-15 | IDARUBICIN + TRETINOIN | null | null | 220030837 | IDARUBICIN + TRETINOIN |
| 220017454 | 220008105 | 1.67 | 59.3 | Disease modification (D) | 2016-06-27 | 2016-06-27 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220030840 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017455 | 220008109 | 1.78 | 74.5 | Curative (C) | 2013-09-26 | 2013-09-27 | BOSUTINIB | 02 | N | 220030849 | BOSUTINIB |
| 220017456 | 220014426 | 1.8 | 85.2 | Disease modification (D) | 2016-09-23 | 2017-12-01 | ATG + Busulfan + Fludarabine | 02 | Y | 220030858 | ATG + BUSULFAN + FLUDARABINE |
| 220017457 | 220008112 | 1.86 | 68.8 | null | 2017-07-17 | 2017-07-17 | FLAG | 02 | N | 220030863 | FLAG |
| 220017458 | 220008112 | null | 9.2 | Curative (C) | 2016-07-29 | 2016-09-21 | AML Int Guide ADE 10+3+5 (1) | 02 | N | 220030863 | ADE |
| 220017459 | 220008115 | null | null | Disease modification (D) | 2014-05-02 | 2018-01-18 | BOSUTINIB | N | null | 220030873 | BOSUTINIB |
| 220017461 | 220008120 | 1.64 | null | null | 2013-08-13 | 2013-12-04 | Idarubicin+Tretinoin Spanish Crse2 | N | N | 220030896 | IDARUBICIN + TRETINOIN |
| 220017463 | 220008126 | null | 104.2 | Palliative (P) | 2017-01-17 | 2017-07-08 | IDARUBICIN + TRETINOIN | 99 | N | 220030906 | IDARUBICIN + TRETINOIN |
| 220017464 | 220008128 | null | 65 | Curative (C) | 2016-07-11 | 2017-03-06 | FLAG | 02 | null | 220030913 | FLAG |
| 220017465 | 220008131 | null | 99.7 | Curative (C) | 2014-02-07 | 2014-02-08 | FLAG | N | N | 220030919 | FLAG |
| 220017466 | 220008134 | 1.83 | 60 | Curative (C) | 2014-01-24 | 2014-01-24 | IDARUBICIN + TRETINOIN | 02 | N | 220030929 | IDARUBICIN + TRETINOIN |
| 220017467 | 220008135 | 1.67 | 78.5 | Curative (C) | 2017-07-18 | 2017-07-19 | Triple Intrathecal | 2 | N | 220030936 | TRIPLE INTRATHECAL |
| 220017468 | 220008137 | 1.62 | 65 | Curative (C) | 2017-08-06 | 2017-08-06 | CYCLOPHOSPHAMIDE | N | N | 220030939 | CYCLOPHOSPHAMIDE |
| 220017469 | 220008138 | null | null | Curative (C) | 2014-05-30 | 2014-06-05 | FLAG | 02 | N | 220030945 | FLAG |
| 220017470 | 220008139 | null | null | Palliative (P) | 2015-03-12 | 2015-03-15 | RUXOLITINIB | N | N | 220030950 | RUXOLITINIB |
| 220017471 | 220008142 | null | 38 | Curative (C) | 2018-08-19 | 2018-08-19 | Triple Intrathecal | N | N | 220030955 | TRIPLE INTRATHECAL |
| 220017473 | 220008152 | null | 80.1 | Disease modification (D) | 2013-11-12 | 2013-11-14 | Triple Intrathecal | 02 | N | 220030962 | TRIPLE INTRATHECAL |
| 220017474 | 220017886 | 1.65 | 14 | Not known (9) | 2014-08-08 | 2014-08-10 | FLAG | N | Y | 220030966 | FLAG |
| 220017475 | 220008158 | 0 | 60 | Palliative (P) | 2014-03-12 | 2014-03-18 | ATG + Busulfan + Fludarabine | 02 | N | 220030971 | ATG + BUSULFAN + FLUDARABINE |
| 220017476 | 220014453 | null | 68.8 | Curative (C) | 2016-05-10 | 2016-05-10 | IDARUBICIN + TRETINOIN | N | N | 220030973 | IDARUBICIN + TRETINOIN |
| 220017477 | 220008161 | 1.75 | 87.3 | Curative (C) | 2018-05-25 | 2018-05-25 | Triple Intrathecal | N | N | 220030983 | TRIPLE INTRATHECAL |
| 220017478 | 220008162 | 0 | 102 | Curative (C) | 2014-08-26 | 2014-08-26 | Cyclophosphamide+Fludara+TBI Allo | 02 | N | 220030983 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017479 | 220008164 | 1.9 | 80.7 | Disease modification (D) | null | 2018-11-08 | AML Int Guide ADE 10+3+5 (1) | 99 | N | 220030991 | ADE |
| 220017481 | 220008167 | null | 59.3 | Curative (C) | null | 2013-05-31 | Cyclophosphamide oral | N | N | 220031002 | CYCLOPHOSPHAMIDE |
| 220017482 | 220014458 | 1.77 | null | Palliative (P) | 2019-03-01 | 2019-03-01 | BOSUTINIB | Y | N | 220031003 | BOSUTINIB |
| 220017483 | 220019818 | 1.7 | null | Palliative (P) | 2018-01-25 | 2018-02-12 | Triple Intrathecal | N | N | 220031027 | TRIPLE INTRATHECAL |
| 220017484 | 220021898 | null | 8.3 | Curative (C) | 2016-03-22 | 2016-08-07 | CYCLOPHOSPHAMIDE + FLUDARABINE | null | null | 220031038 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017485 | 220008177 | 1.51 | 79.8 | Adjuvant (A) | 2014-10-26 | 2014-10-26 | RUXOLITINIB | 02 | N | 220031045 | RUXOLITINIB |
| 220017486 | 220008179 | 1.7 | null | Disease modification (D) | 2015-12-29 | 2016-01-10 | BOSUTINIB | 2 | N | 220031046 | BOSUTINIB |
| 220017487 | 220020930 | 1.71 | null | Curative (C) | 2017-11-29 | 2017-12-03 | Cyclophosphamide TBI Allograft | N | N | 220031047 | CYCLOPHOSPHAMIDE |
| 220017488 | 220008182 | 1.58 | 56.7 | Curative (C) | 2018-01-30 | 2018-01-30 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 220031049 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220017489 | 220014464 | null | 83.1 | null | null | 2015-01-03 | FLAG | null | N | 220031051 | FLAG |
| 220017490 | 220014464 | 1.93 | 87.8 | Curative (C) | 2017-08-27 | 2017-08-27 | BOSUTINIB | 2 | null | 220031051 | BOSUTINIB |
| 220017491 | 220008185 | 0 | 9.2 | Disease modification (D) | 2018-02-15 | 2018-04-02 | RUXOLITINIB | 2 | N | 220031065 | RUXOLITINIB |
| 220017492 | 220008187 | null | 78.6 | Palliative (P) | null | 2014-06-15 | Idarubicin+Tretinoin Spanish Crse2 | N | N | 220031084 | IDARUBICIN + TRETINOIN |
| 220017493 | 220008188 | 1.67 | 54.6 | Curative (C) | 2018-12-18 | 2018-12-18 | FLAG | N | N | 220031093 | FLAG |